Health News Releases

  • Today April 22
November 11, 2022 16:25
European Commission (EC) Approves LIVTENCITYTM▼ (maribavir) for the Treatment of Adults With Post-transplant Cytomegalovirus (CMV) Infection And/or Disease That Are Refractory (With or Without Resistance) to One or More Prior Therapies
Takeda (TSE:4502/NYSE:TAK) today announced that the European Commission (EC) has granted Marketing Authorization for LIVTENCITYTM (maribavir) for the treatment of cytomegalovirus (CMV) infection and/o
November 11, 2022 15:40
Kirin Holdings and Kao Begin Joint Research On The Relationship Between Visceral Fat and Immunology
Kirin Holdings Company, Limited (Kirin Holdings) and Kao Corporation (Kao) will participate in the “Wakayama Health Promotion Study” cohort study[*1] led by Wakayama Medical University and compiled by
Top US board-certified plastic surgeons were invited to Moonlight Sylfirm X Global Symposium 2022, a
November 11, 2022 10:59
RF Micro-needling Device, Sylfirm X Recognized by Top US Aesthetic Dermatologists
VIOL Co., Ltd hosted the first global event called ‘Moonlight Sylfirm X Global Symposium 2022’ on September 18th, at the Grand Mercure Hotel, Seoul. The Symposium invited renowned domestic aesthetic d
November 10, 2022 11:58
Dong-A ST Out License NESP® Biosimilar DA-3880 to Polifarma of Türkiye
Dong-A ST (Min Young Kim, President and CEO) (KRX: 170900) announced that they signed an exclusive license-out and supply agreement on November 4, 2022, with Polifarma (Mehmet Asri, CEO) for NESP® bio
November 08, 2022 14:10
Merck, Synergis & IPS Present on Engineering Document Management for Simplified Compliance & Validation
Synergis Software, a global leader in engineering document management and workflow solutions, today announced they will participate in a collaborative, live panel with leaders from Merck, known as MSD
November 08, 2022 11:30
LevitasBio Completes Series C Financing
LevitasBio, Inc., www.levitasbio.com, a premier end-to-end sample processing and analysis provider to the life sciences market, announced it has completed Series C round financing of $35 million to ad
November 07, 2022 11:50
Landmark EMPA-KIDNEY trial showed significant benefit of Jardiance® in reducing kidney disease progression or cardiovascular death by 28% vs. placebo in people with chronic kidney disease
EMPA-KIDNEY Phase III clinical trial met its primary endpoint by demonstrating a significant kidney and cardiovascular benefit for adults living with chronic kidney disease (CKD).[1,2] When treated wi
November 07, 2022 10:10
Aster Guardians Global Nursing Award 2023 worth $250,000 to be held in London
Aster DM Healthcare, one of the largest integrated healthcare providers in GCC and India, has announced London as the next destination for Aster Guardians Global Nursing Award 2023 ceremony. The award
November 04, 2022 15:00
SINOVAC Varicella Vaccine Prequalified by WHO
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it received prequalification from the World Health Orga
November 03, 2022 16:35
Seven pharma CEOs announce new joint action to accelerate net zero healthcare
CEOs from AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Samsung Biologics and Sanofi today announced joint action to achieve near-term emissions reduction targets and accelerate the delivery of n
November 03, 2022 13:50
CureApp: Digital Therapeutic App for Hypertension Receives Insurance Coverage, Sales of the Service to Medical Institutions Across Japan Launch on September 1
CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) announces the start of insurance coverage for its CureApp HT Hypertension Adjunctive Treatment App (hereafter, CureApp HT), a DTx[*1] sol
November 02, 2022 13:10
OUI Inc., the Japanese Startup of a Smartphone-based Ophthalmic Diagnostic Medical Device, Wins First Prize at AEA2022 Innovation Awards
The Asian Entrepreneurship Award 2022 event (AEA2022) was held fully online from Wednesday, October 26th to Thursday, October 27th with the participation of 24 tech startups selected from Asian countr
November 01, 2022 14:30
Eucure Biopharma, a Subsidiary of Biocytogen, Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence
Eucure Biopharma, a China-based clinical-stage biotechnology company focused on the development of antibody therapeutics, announced today that it has entered into a collaborative agreement with ISU AB
October 31, 2022 10:40
SINOVAC to Showcase Products at CPHI Frankfurt
Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced that the Company will participate in CPHI Frankfurt, one of the wo
CLECELL and CancerFree Biotech logo
October 28, 2022 16:54
CLECELL and CancerFree Biotech Jointly Develop Anti-cancer Drug Sensitivity Testing Services
3D bioprinting company CLECELL announced that it had signed an MoU with Taiwanese bio company CancerFree Biotech for the commercialization of an organoid-based anti-cancer drug sensitivity test. Si
October 28, 2022 15:30
SYNLAB and Microba reinforce their combined expertise and expand strategic agreement on advanced gut microbiome test myBIOME
SYNLAB, the leader in medical diagnostic services and specialty testing in Europe, and Microba Life Sciences (Microba), a global leader in the analysis of complex gut microbiomes, have expanded their
October 28, 2022 14:40
Takeda Delivers Strong FY2022 H1 Results and Raises Full-Year Forecast
Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for the first half of fiscal year 2022 (period ended September 30, 2022), upgrading reported and core forecasts and free cash flow outloo
October 28, 2022 10:45
Medisca to Open New Plattsburgh, NY Facility Exceeding Rigorous Quality and Employee Safety Standards
Medisca, a global company offering pharmaceutical compounding products and services, mixing technology, manufacturing, education services and more, announces plans to lease a standalone 60,000 square
October 28, 2022 10:00
Boehringer Ingelheim Extends the Use of Medidata Rave for Electronic Data Capture in Clinical Trials
Medidata, a Dassault Systèmes company, and Boehringer Ingelheim today announced a five-year renewal of their collaboration in the wider area of electronic data capture. The new agreement extends the u
October 26, 2022 17:25
Merck Showcases Depth of MS Portfolio at ECTRIMS Supporting Commitment to Advancing MS Care
Merck, a leading science and technology company, today announced it will present 39 abstracts at the 38th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS),
October 26, 2022 16:57
Merck Highlights New Data for Evobrutinib, First BTKi to Demonstrate Sustained Clinical Benefit for People with RMS through Three and a Half Years of Treatment
Merck, a leading science and technology company, today announced findings which demonstrated that annualized relapse rates (ARR) remained low and Expanded Disability Status Scale (EDSS) scores were st
October 25, 2022 16:55
Ferring Presents Seven New Analyses at ACG 2022 for RBX2660, Its Investigational Microbiota-Based Live Biotherapeutic
Ferring Pharmaceuticals today announced the presentation at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting of seven analyses for RBX2660, an investigational microbiota-b
October 25, 2022 14:55
Neuraptive Therapeutics Announces Key Organizational Updates to Support the Company’s Advancements in Nerve Repair
Neuraptive Therapeutics, Inc., a biotechnology company dedicated to developing novel therapeutics and medical products to address the unmet needs of physicians and patients impacted by peripheral nerv
October 25, 2022 13:30
DentalMonitoring Now Offers Smart STL[*] Powered by AI-driven Technology
DentalMonitoring now offers Smart STL[*] powered by AI-driven technology. The company brings the only platform in the oral healthcare industry capable of creating updated STL files 100% remotely[*]. T
October 25, 2022 10:50
Urethral Stricture: BEES-HAUS Cell Therapy Approach Proven With Cell Engraftment by Urologists of Edogawa Hospital, Japan, Holds Potential to Prevent Recurrence.
Urethral stricture, blocking the passage of urine from the bladder in men, could be solved by BEES-HAUS cell therapy, a novel autologous buccal mucosal cell-based approach as reported by Dr. Akio Hori
25 per page50 per page75 per page100 per page